Hypermarcas (OTCMKTS:HYPMY) Shares Climb 8% – Time to Buy?

Posted by Teresa Graham on Oct 1st, 2026

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) shares were up 8% on Thursday. The stock traded as high as $4.99 and last traded at $4.99. Approximately 1,842 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 19,484 shares. The stock had previously closed at $4.62.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised shares of Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy”.

Read Our Latest Analysis on HYPMY

Hypermarcas Price Performance

The stock has a market capitalization of $3.31 billion, a PE ratio of 9.40 and a beta of 0.71. The company has a quick ratio of 1.26, a current ratio of 1.86 and a debt-to-equity ratio of 0.50. The stock’s 50 day moving average price is $4.31 and its 200-day moving average price is $4.32.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 12.68%. As a group, equities analysts forecast that Hypermarcas will post 0.53 EPS for the current year.

Hypermarcas Company Profile

(Get Free Report)

Hypermarcas SA was a Brazilian consumer healthcare company that developed, manufactured and marketed pharmaceutical and healthcare products. Its portfolio included over-the-counter medicines, prescription products, vitamins and other consumer health brands sold through pharmacies and retail channels.

The company was historically associated with well-known Brazilian brands such as Benegrip, Biotônico Fontoura, Doril, Engov and Epocler. Hypermarcas also previously operated in personal care, beauty, household cleaning and other consumer categories, but divested many of those businesses as it concentrated on pharmaceuticals and healthcare.

In 2018, Hypermarcas changed its corporate name to Hypera SA, adopting the Hypera Pharma identity.